269 related articles for article (PubMed ID: 19448134)
1. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor.
Braeuning A; Buchmann A
Drug Metab Dispos; 2009 Aug; 37(8):1576-80. PubMed ID: 19448134
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of structurally different aryl hydrocarbon receptor agonists and β-catenin in the regulation of CYP1A expression.
Vaas S; Kreft L; Schwarz M; Braeuning A
Toxicology; 2014 Nov; 325():31-41. PubMed ID: 25174530
[TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway.
Braeuning A; Köhle C; Buchmann A; Schwarz M
Toxicol Sci; 2011 Jul; 122(1):16-25. PubMed ID: 21498875
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
6. Mixed-ligand copper(II) complexes activate aryl hydrocarbon receptor AhR and induce CYP1A genes expression in human hepatocytes and human cell lines.
Kubešová K; Dořičáková A; Trávníček Z; Dvořák Z
Toxicol Lett; 2016 Jul; 255():24-35. PubMed ID: 27180721
[TBL] [Abstract][Full Text] [Related]
7. The interplay of the aryl hydrocarbon receptor and β-catenin alters both AhR-dependent transcription and Wnt/β-catenin signaling in liver progenitors.
Procházková J; Kabátková M; Bryja V; Umannová L; Bernatík O; Kozubík A; Machala M; Vondrácek J
Toxicol Sci; 2011 Aug; 122(2):349-60. PubMed ID: 21602191
[TBL] [Abstract][Full Text] [Related]
8. ShRNA-mediated gene silencing of AHR promotes the differentiation of P19 mouse embryonic carcinoma cells into cardiomyocytes.
Zhu C; Chen YL; Wang XJ; Hu XS; Yu ZB; Han SP
Mol Med Rep; 2012 Sep; 6(3):513-8. PubMed ID: 22684894
[TBL] [Abstract][Full Text] [Related]
9. Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T.
Kamenickova A; Anzenbacherova E; Pavek P; Soshilov AA; Denison MS; Anzenbacher P; Dvorak Z
Toxicol Lett; 2013 Apr; 218(3):253-9. PubMed ID: 23419638
[TBL] [Abstract][Full Text] [Related]
10. Quinone-mediated induction of cytochrome P450 1A1 in HepG2 cells through increased interaction of aryl hydrocarbon receptor with aryl hydrocarbon receptor nuclear translocator.
Abiko Y; Lin FY; Lee H; Puga A; Kumagai Y
J Toxicol Sci; 2016; 41(6):775-781. PubMed ID: 27853106
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
13. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes.
Dvorak Z; Vrzal R; Henklova P; Jancova P; Anzenbacherova E; Maurel P; Svecova L; Pavek P; Ehrmann J; Havlik R; Bednar P; Lemr K; Ulrichova J
Biochem Pharmacol; 2008 Jan; 75(2):580-8. PubMed ID: 17959153
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Solaimani P; Damoiseaux R; Hankinson O
Toxicol Sci; 2013 Nov; 136(1):107-19. PubMed ID: 23997114
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components.
Lee C; Riddick DS
Can J Physiol Pharmacol; 2012 Oct; 90(10):1354-63. PubMed ID: 22978700
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.
DiNatale BC; Murray IA; Schroeder JC; Flaveny CA; Lahoti TS; Laurenzana EM; Omiecinski CJ; Perdew GH
Toxicol Sci; 2010 May; 115(1):89-97. PubMed ID: 20106948
[TBL] [Abstract][Full Text] [Related]
20. Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells.
Vyhlídalová B; Poulíková K; Bartoňková I; Krasulová K; Vančo J; Trávníček Z; Mani S; Dvořák Z
Toxicol Lett; 2019 Oct; 313():66-76. PubMed ID: 31201936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
